LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_002944.2:c.6068A>T
ROS1
· NP_002935.2:p.(Tyr2023Phe)
· NM_002944.2
GRCh37: chr6:117638373 T>A
·
GRCh38: chr6:117317210 T>A
Gene:
ROS1
Transcript:
NM_002944.2
Final call
VUS
PM2 supporting
Variant details
Gene
ROS1
Transcript
NM_002944.2
Protein
NP_002935.2:p.(Tyr2023Phe)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent (AF = 0) from gnomAD v2.1 exomes, gnomAD v4.1 exomes, and gnomAD-Canada v1.0 genomes, three independent population datasets.
2
VUS: a single Supporting PM2 satisfies no ACMG/AMP 2015 combination rule for Pathogenic, Likely Pathogenic, Benign, or Likely Benign.
Final determination:
Under the generic ACMG/AMP 2015 fallback combination rules (no ROS1 VCEP/CSPEC exists; final_classification_framework found=false), only PM2 at Supporting strength is met; no Pathogenic, Likely Pathogenic, Benign, or Likely Benign combination is satisfied, so the variant resolves to Uncertain Significance (VUS).
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 applies only to null variants, and this missense substitution (p.Tyr2023Phe) triggers no null-variant mechanism. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: no ClinVar record or literature reports exist, so no same-amino-acid pathogenic comparator (p.Tyr2023Phe) was available. |
clinvar
pm5_candidates
|
| PS2 | Not assessed | Not assessed: no proband phenotype, family history, or parental genotyping data were available to evaluate a de novo origin. |
clinvar
generic_acmg_combination_rules
|
| PS3 | Not assessed | Not assessed: no functional studies exist for this variant; OncoKB reports unknown oncogenic effect. |
oncokb
spliceai
generic_acmg_combination_rules
|
| PS4 | Not assessed | Not assessed: no case-control or cohort allele-frequency comparison exists for this variant. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| PM1 | Not met | Not met: no statistically significant hotspot at ROS1 Y2023, and no curated ROS1 domain map supports this position. Flagged for human review: no named curated ROS1 domain/hotspot map was available. |
|
| PM2 | Met | Met (Supporting): absent (AF = 0) from gnomAD v2.1, gnomAD v4.1, and gnomAD-Canada v1.0, three independent population datasets. Per-position coverage at this site could not be independently verified. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| PM3 | N/A | Not applicable: PM3 applies only to recessive disorders, and no recessive germline mechanism is established for ROS1. |
generic_acmg_combination_rules
clinvar
pvs1_gene_context
|
| PM4 | N/A | Not applicable: this missense substitution produces no protein length change, which PM4 requires. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: no pathogenic variant at the same residue (p.Tyr2023) was identified for comparison. |
pm5_candidates
clinvar
|
| PM6 | Not assessed | Not assessed: no de novo occurrence or parental testing results were reported for this variant. |
clinvar
generic_acmg_combination_rules
|
| PP1 | Not assessed | Not assessed: no pedigree or family segregation data exist for this variant. |
clinvar
generic_acmg_combination_rules
|
| PP2 | Not assessed | Not assessed: no ROS1 missense-constraint data (e.g., gnomAD Z-score) were available. |
pvs1_gene_context
oncokb
|
| PP3 | Not met | Not met: SpliceAI max delta 0.01 predicts no splice impact, and REVEL 0.52 is uninformative (below 0.773, above 0.016). |
spliceai
revel
bayesdel
generic_acmg_combination_rules
|
| PP4 | Not assessed | Not assessed: no carrier phenotype or clinical case description was available for this variant. |
oncokb
generic_acmg_combination_rules
|
| PP5 | Not met | Not met: this variant has no ClinVar record, so no expert-panel pathogenic classification exists to support PP5. |
clinvar
generic_acmg_combination_rules
|
| BA1 | Not met | Not met: allele frequency is 0 in all queried population databases, far below the >5% BA1 threshold. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| BS1 | Not met | Not met: absent (AF = 0) from population databases, so the frequency cannot exceed any disease-consistent threshold. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| BS2 | Not met | Not met: no healthy-adult carriers of this variant were observed in any population cohort. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| BS3 | Not assessed | Not assessed: no functional studies demonstrating a benign effect on protein function or splicing exist. |
oncokb
spliceai
clinvar
generic_acmg_combination_rules
|
| BS4 | Not assessed | Not assessed: no family segregation testing data exist for this variant. |
clinvar
generic_acmg_combination_rules
|
| BP1 | Not met | Not met: ROS1 disease is not limited to truncating variants; non-truncating alterations are disease-relevant. |
pvs1_gene_context
oncokb
|
| BP2 | Not assessed | Not assessed: no allele-phase (trans/cis) observation with a pathogenic variant exists for this variant. Flagged for human review: no external family or allele-phase data were available. |
generic_acmg_combination_rules
clinvar
pvs1_gene_context
|
| BP3 | N/A | Not applicable: BP3 applies to in-frame indels in repeat regions, not missense substitutions. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: only SpliceAI (max delta 0.01) supports no impact, and REVEL 0.52 is uninformative, so the multiple-lines requirement fails. |
spliceai
revel
bayesdel
generic_acmg_combination_rules
|
| BP5 | Not assessed | Not assessed: no proband-level data exist to evaluate an alternative molecular basis for disease. |
generic_acmg_combination_rules
|
| BP6 | Not met | Not met: this variant has no ClinVar record, so no expert-panel benign classification exists to support BP6. |
clinvar
generic_acmg_combination_rules
|
| BP7 | N/A | Not applicable: BP7 applies only to synonymous variants, and this is a missense substitution. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.